Leukemia Research
Volume 24, Issue 12 , Pages 1033-1039 , December 2000

Granulocyte-colony stimulating factor induced intranuclear endonuclease in murine leukemia cell line

Received 9 February 2000 ,Accepted 22 May 2000.

References 

  1. Fawthrop DJ, Boobis AR, Davies DS. Mechanisms of cell death. Arch. Toxicol. 1991;65:437–444
  2. Allen PD, Bustin SA, Newland AC. The role of apoptosis (programmed cell death) in haemopoiesis and the immune system. Blood Rev. 1993;7:63–73
  3. Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nunez G, et al.  c-Myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc. Natl. Acad. Sci. USA. 1994;91:5878–5882
  4. Hermeking H, Eick D. Mediation of c-myc-induced apoptosis by p53. Science. 1994;265:2091–2093
  5. Kawabata H, Anzai N, Ueda Y, Masutani H, Hirama T, Yoshida Y, et al.  High levels of Ca(2+)-independent endonuclease activity capable of producing nucleosomal-size DNA fragmentation in non-adherent marrow mononuclear cells from patients with myelodysplastic syndromes and acute myelogenous leukemia. Leukemia. 1996;10:67–73
  6. Kawabata H, Anzai N, Masutani H, Hirama T, Hishita T, Dodo M, et al.  Mg2+- or Mn2+-dependent endonuclease activities of human myeloid leukemia cells capable of producing nucleosomal-size DNA fragmentation. Biochem. Biophys. Res. Commun. 1997;233:133–138
  7. Drexler HG, Zaborski M, Quentmeier H. Cytokine response profiles of human myeloid factor-dependent leukemia cell lines. Leukemia. 1997;11:701–708
  8. Kawai N, Bessho M, Hirashima K. A new cell line of murine myeloid leukemia with A-type phosphoglycerate kinase as marker isoenzyme. Leuk. Res. 1988;12:911–916
  9. Bessho M, Yoshida S, Sakate K, Murohashi I, Jinnai I, Hirashima K. Suppression of the development of murine myeloid leukemia with granulocyte colony-stimulating factor by inducting apoptosis of leukemia cells. Leukemia. 1994;8:1185–1190
  10. Brach MA, deVos S, Gruss HJ, Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood. 1992;80:2920–2924
  11. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood. 1991;78:2791–2808
  12. Rodel JE, Link DC. Suppression of apoptosis during cytokine deprivation of 32D cells is not sufficient to induce complete granulocytic differentiation. Blood. 1996;87:858–864
  13. Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, et al.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986;232:61–65
  14. Handa A, Kashimura T, Kawano N, Yamamoto A, Yoshida S, Jinnai I, et al.  Granulocyte-colony stimulating factor induced apoptosis in radiation-induced murine leukemia cell line. Leukemia (Suppl). 1997;3:387–388
  15. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature. 1990;343:76–79
  16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987;162:156–159
  17. Thomas PS. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA. 1980;77:5201–5205
  18. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 1992;119:493–501
  19. Rosenthal AL, Lacks SA. Nuclease detection in SDS-polyacrylamide gel electrophoresis. Anal. Biochem. 1977;15:76–90
  20. Kohno T, Yoshida S, Bessho M. Accerlerated entry into S phase associated with up-regulation of cyclin D1 as a mechanism for granulocyte colony-stimulating factor (G-CSF)-induced apoptosis of murine myeloid leukemia cells. Leuk. Res. 1998;22:257–263
  21. Trudel M, Lanoix J, Barisoni L, Blouin MJ, Desforges M, L'Italien C, et al.  C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J. Exp. Med. 1997;186:1873–1884
  22. Green DR. A myc-induced apoptosis pathway surfaces. Science. 1997;278:1246–1247
  23. Moore J, Boswell S, Hoffman R, Burgess G, Hromas R. Mutant H-ras over- expression inhibits a random apoptotic nuclease in myeloid leukemia cells. Leuk. Res. 1993;17:703–709
  24. Arends MJ, McGregor AH, Toft NJ, Brown EJ, Wyllie AH. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br. J. Cancer. 1993;68:1127–1133
  25. Blagosklonny MV, El-Deiry WS. Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. Int. J. Cancer. 1998;75:933–940
  26. Van Parijs L, Biuckians A, Abbas AK. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J. Immunol. 1998;160:2065–2071
  27. Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z, et al.  Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am. J. Hematol. 1995;48:143–154
  28. Yanagisawa-Shiota F, Sakagami H, Kuribayashi N, Iida M, Sakagami T, Takeda M. Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines. Anticancer Res. 1995;15:259–265
  29. McConkey DJ, Chandra J, Wright S, Plunkett W, McDonnell TJ, Reed JC, et al.  Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J. Immunol. 1996;156:2624–2630
  30. Matsubara K, Kubota M, Kuwakado K, Hirota H, Wakazono Y, Okuda A, et al.  Variable susceptibility to apoptosis induced by calcium ionophore in hybridomas between HL-60 promyelocytic and CEM T-lymphoblastic leukemia cell lines: relationship to constitutive Mg(2+)-dependent endonuclease. Exp. Cell Res. 1994;213:412–417
  31. Compton MM, Cidlowski JA. Identification of a glucocorticoid-induced nuclease in thymocytes. A potential ‘lysis gene’ product. J. Biol. Chem. 1987;262:8288–8292
  32. Wyllie AH, Arends MJ, Morris RG, Walker SW, Evan G. The apoptosis endonuclease and its regulation. Semin. Immunol. 1992;4:389–397
  33. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 1998;391:96–99
  34. Mukae N, Enari M, Sakahira H, Fukuda Y, Inazawa J, Toh H, et al.  Molecular cloning and characterization of human caspase-activated DNase. Proc. Natl. Acad. Sci. USA. 1998;95:9123–9128

PII: S0145-2126(00)00074-6

doi: 10.1016/S0145-2126(00)00074-6

Leukemia Research
Volume 24, Issue 12 , Pages 1033-1039 , December 2000

Article Tools

* Image Usage & Resolution